Characteristics | Total | non-CLT(%) | CLT-coexisted(%) | OR(95%CI) | P value |
---|---|---|---|---|---|
Number of patients | 635 | 447 (70.1) | 188 (29.6) | Â | Â |
Sex | |||||
Female | 484 | 315 (70.5) | 169 (89.9) | 3.7 (2.2–6.2) |  < 0.001 |
Male | 151 | 132 (29.5) | 19 (10.1) | Â | Â |
Age | |||||
 < 55 | 515 | 366 (71.1) | 149 (28.9) | 1.1 (0.8–1.6) | 0.49 |
 ≥ 55 | 120 | 81 (67.5) | 39 (32.5) |  |  |
#Mean rank of lesion size | Â | 307.67 | 342.55 | Â | 0.017 |
0 < size ≤  1 cm |  | 240 (53.7) | 85 (45.2) |  |  |
1 cm < size ≤ 2 cm |  | 95 (21.3) | 38 (20.2) | ||
2 cm < size ≤ 4 cm |  | 108 (24.2) | 61 (32.4) | ||
4 cm < size |  | 4 (0.9) | 4 (2.1) | ||
Small lesion (Dmax ≤ 1 cm) | 325 | 240 (53.7) | 85 (45.2) | 1.4 (1.0–2.0) | 0.05 |
Extrathyroidal extension | 143 | 94 (21.0) | 49 (26.1) | 1.3 (0.9–2.0) | 0.17 |
CLNM | 297 | 219 (49.0) | 78 (41.5) | 0.7 (0.5–1.0) | 0.08 |
LLNM | 54 | 40 (8.9) | 14 (7.4) | 0.8 (0.4–1.5) | 0.54 |
CLNM of small lesions | 145 | 119(40.3) | 26 (24.3) | 0.5 (0.3–0.8) | 0.003 |
TNM stage | |||||
I | 623 | 438 (98.0) | 185 (98.4) | 0.8 (0.2–2.9) | 0.72 |
II-IV | 12 | 9 (2.0) | 3 (1.6) | Â | Â |
Multifocality | 194 | 133 (29.8) | 61 (33.0) | 1.2 (0.8–1.7) | 0.43 |
MACIS score | |||||
 < 6 | 595 | 417 (93.3) | 178 (94.7) | 1.3 (0.6–2.7) | 0.51 |
6–6.99 | 31 | 24 (5.4) | 7 (3.7) | 0.7 (0.3–1.6) | 0.38 |
7–7.99 | 9 | 6 (1.3) | 3 (1.6) | 1.2 (0.3–4.8) | 0.81 |
High-risk recurrence | 143 | 94 (21.0) | 49 (26.1) | 1.3 (0.9–2.0) | 0.17 |